by The Tutu Team | Apr 5, 2017 | Uncategorized
Author: Laura Panjwani / Source: Research & Development Patients with triple-negative breast cancer (TNBC) — a subtype which accounts for 10 to 20% of all breast cancers— have very few treatment options. Targeted therapies, which are used to treat many... 